MedPath

Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients

Completed
Conditions
Acute Kidney Injury
Registration Number
NCT05424874
Lead Sponsor
AlgoDx
Brief Summary

The study aims to evaluate the performance of the prediction algorithm NAVOY® AKI in a Swedish adult ICU patient population versus fulfilment of KDIGO diagnostic criteria.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
304
Inclusion Criteria
  • The study will only include the subjects from the SEP-SE-02 study population. (NCT04570618)
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prediction performance of NAVOY® AKIData from ICU stay between December 2020 to October 2021.

The sensitivity, specificity, and accuracy will be calculated comparing the algorithm's predictions with the true AKI outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Intensiv- och perioperativ vård

🇸🇪

Malmö, Sweden

Intensiv- och perioperativ vård
🇸🇪Malmö, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.